Pancreatic cancer screening: Identifying premalignant disease

Future Oncology

Volumn 1, Issue 2, 2005, Pages 191-195

  James, T A ^b   Gibbs, John F ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NONE

Author keywords

cancer; endoscopy; pancreas; pancreatic intraepithelial; screening

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FORECASTING; GENETIC PREDISPOSITION; GENETICS; HUMAN; MASS SCREENING; PANCREAS TUMOR; PRECANCER; REVIEW;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; ENDOSONOGRAPHY; FORECASTING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASS SCREENING; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33646452801     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.1517/14796694.1.2.191     Document Type: Article

References (25)

1. Canto MI, Goggins M, Yeo CJ et al.: Screening for pancreatic neoplasia in highrisk individuals: an EUS-based approach. Clin. Gastroenterol. Hepatol. 2(7), 606-621 (2004)
2. Jemal A,Murray T, Ward E et al.: Cancer statistics, 2005. CA Cancer J. Clin. 55(1), 10-30 (2005)
3. Michaud DS: Epidemiology of pancreatic cancer. Minerva Chir. 59(2), 99-111 (2004)
4. US Preventive Services Task Force: Screening for Pancreatic Cancer. (2004)
5. Petersen GM, Hruban RH: Familial Pancreatic Cancer: Where are we in 2003? J. Natl Cancer Inst. 95(3), 180-181 (2003)
6. Lim JE, Chien MW, Earle CC: Prognostic factors following curative resection for pancreatic adenocarcinoma: a populationbased, linked database analysis of 396 patients. Ann. Surg. 237(1), 74-85 (2003)
7. Sohn TA, Yeo CJ, Cameron JL et al.: Resected adenocarcinoma of the pancreas- 616 patients: results, outcomes, and prognostic indicators. J. Gastrointest. Surg. 4(6), 567-579 (2000)
8. Varadarajulu S, Wallace MB: Applications of endoscopic ultrasonography in pancreatic cancer. Cancer Control 11(1), 15-22 (2004)
9. Eloubeidi MA, Chen VK, Eltoum IA et al.: Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am. J. Gastroenterol. 98(12), 2663-2668 (2003)
10. Vimalachandran D, Ghaneh P, Costello E et al.: Genetics and prevention of pancreatic cancer. Cancer Control 11(1), 6-14 (2004)
11. Ghadirian P, Lynch HT, Krewski DL: Epidemiology of pancreatic cancer: an overview. Cancer Detect. Prev. 27(2), 87-93 (2003)
12. Klein AP, Brune KA, Petersen GM et al.: Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 64(7), 2634-2638 (2004)
13. Hruban RH, Takaori K, Klimstra DS et al.: An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am. J. Surg. Pathol. 28(8), 977-987 (2004)
14. Takaori K, Hruban RH, Maitra A et al.: Pancreatic intraepithelial neoplasia. Pancreas 28(3), 257-262 (2004)
15. Harvey SR, Hurd TC, Markus G et al.: Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer. Clin. Cancer Res. 9(13), 4935-4943 (2003)
16. Kimmey MB, Bronner MP, Byrd DR et al.: Screening and surveillance for hereditary pancreatic cancer. Gastrointest. Endosc. 56(4 Suppl.), S82-S86 (2002)
17. Ulrich CD: Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment. Pancreatology 1(5), 416-422 (2001)
18. Chen, VK, Arguedas MR, Kilgore ML et al.: A cost-minimization analysis of alternative strategies in diagnosing pancreatic cancer. Am. J. Gastroenterol. 99(11), 2223-2234 (2004)
19. Rulyak SJ, Kimmey MB, Veenstra DL et al.: Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest. Endosc. 57(1), 23-29 (2003)
20. Ueki T, Toyota I, Sohn T et al.: DNA hypermethylation in pancreatic carcinoma. Cancer Res. 60, 1835-1839 (2000)
21. Shekouh AR, Thompson CC, Prime W et al.: Application of laser capture microdissection combined with twodimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 3(10), 1988-2001 (2003)
22. Crnogorac-Jurcevic T, Efthimiou E, Nielsen T et al.: Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 21(29), 4587-4594 (2002)
23. Wolff RA: Chemoprevention for pancreatic cancer. Int. J. Gastrointest. Cancer 33(1), 27-41 (2003)
24. Anderson KE, Johnson TW, Lazovich D et al.: Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J. Natl Cancer Inst. 94(15), 1168-1171 (2002)
25. Canto MI,Goggins M, Yeo CJ et al: Screening for pancreatic neoplasia in highrisk individuals: An EUS-based approach. Clin. Gastroenter. Hepatol. 2, 606-621 (2004)